Suraj Kalia
Stock Analyst at Oppenheimer
(3.85)
# 707
Out of 5,043 analysts
84
Total ratings
46.48%
Success rate
12.02%
Average return
Main Sectors:
Stocks Rated by Suraj Kalia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EW Edwards Lifesciences | Downgrades: Perform | n/a | $80.82 | - | 6 | Oct 8, 2025 | |
| PRCT PROCEPT BioRobotics | Upgrades: Outperform | $60 | $36.35 | +65.06% | 2 | Sep 2, 2025 | |
| PLSE Pulse Biosciences | Initiates: Outperform | $22 | $17.50 | +25.71% | 1 | Jul 7, 2025 | |
| TMDX TransMedics Group | Maintains: Outperform | $130 → $150 | $132.45 | +13.25% | 11 | Jun 17, 2025 | |
| ATRC AtriCure | Maintains: Outperform | $36 → $45 | $36.47 | +23.39% | 7 | Feb 13, 2025 | |
| VREX Varex Imaging | Maintains: Outperform | $30 → $23 | $11.92 | +92.95% | 6 | Feb 7, 2025 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $105 → $120 | $182.71 | -34.32% | 6 | Jan 8, 2025 | |
| AORT Artivion | Maintains: Outperform | $30 → $32 | $44.74 | -28.48% | 3 | Nov 8, 2024 | |
| LMAT LeMaitre Vascular | Reiterates: Outperform | $90 → $93 | $90.12 | +3.20% | 2 | Nov 1, 2024 | |
| ABT Abbott Laboratories | Initiates: Outperform | $130 | $127.18 | +2.22% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $10 | $5.02 | +99.20% | 1 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $13 | $5.29 | +145.75% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $135 | $70.20 | +92.31% | 1 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $259.21 | - | 6 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $30 | $15.00 | +100.00% | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $320 → $200 | $2.08 | +9,515.38% | 1 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $97 | $78.35 | +23.80% | 1 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $28.04 | -0.14% | 4 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $4.5 | $2.20 | +104.55% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $1.68 | +852.38% | 1 | Sep 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $551.25 | - | 3 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $660 | $2.19 | +30,036.99% | 2 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $78.20 | - | 2 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Perform | n/a | $4.03 | - | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $100 | $23.17 | +331.59% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $70.63 | - | 5 | Sep 12, 2018 |
Edwards Lifesciences
Oct 8, 2025
Downgrades: Perform
Price Target: n/a
Current: $80.82
Upside: -
PROCEPT BioRobotics
Sep 2, 2025
Upgrades: Outperform
Price Target: $60
Current: $36.35
Upside: +65.06%
Pulse Biosciences
Jul 7, 2025
Initiates: Outperform
Price Target: $22
Current: $17.50
Upside: +25.71%
TransMedics Group
Jun 17, 2025
Maintains: Outperform
Price Target: $130 → $150
Current: $132.45
Upside: +13.25%
AtriCure
Feb 13, 2025
Maintains: Outperform
Price Target: $36 → $45
Current: $36.47
Upside: +23.39%
Varex Imaging
Feb 7, 2025
Maintains: Outperform
Price Target: $30 → $23
Current: $11.92
Upside: +92.95%
iRhythm Technologies
Jan 8, 2025
Maintains: Outperform
Price Target: $105 → $120
Current: $182.71
Upside: -34.32%
Artivion
Nov 8, 2024
Maintains: Outperform
Price Target: $30 → $32
Current: $44.74
Upside: -28.48%
LeMaitre Vascular
Nov 1, 2024
Reiterates: Outperform
Price Target: $90 → $93
Current: $90.12
Upside: +3.20%
Abbott Laboratories
Oct 8, 2024
Initiates: Outperform
Price Target: $130
Current: $127.18
Upside: +2.22%
Sep 16, 2024
Initiates: Outperform
Price Target: $10
Current: $5.02
Upside: +99.20%
Aug 7, 2024
Maintains: Outperform
Price Target: $15 → $13
Current: $5.29
Upside: +145.75%
Jul 16, 2024
Initiates: Outperform
Price Target: $135
Current: $70.20
Upside: +92.31%
Jun 25, 2024
Downgrades: Perform
Price Target: n/a
Current: $259.21
Upside: -
Aug 8, 2023
Maintains: Outperform
Price Target: $24 → $30
Current: $15.00
Upside: +100.00%
Jun 23, 2023
Maintains: Outperform
Price Target: $320 → $200
Current: $2.08
Upside: +9,515.38%
May 16, 2023
Initiates: Outperform
Price Target: $97
Current: $78.35
Upside: +23.80%
Mar 6, 2023
Reiterates: Outperform
Price Target: $28
Current: $28.04
Upside: -0.14%
Nov 29, 2022
Initiates: Outperform
Price Target: $4.5
Current: $2.20
Upside: +104.55%
Sep 24, 2021
Initiates: Outperform
Price Target: $16
Current: $1.68
Upside: +852.38%
Apr 21, 2021
Upgrades: Perform
Price Target: n/a
Current: $551.25
Upside: -
Nov 17, 2020
Upgrades: Outperform
Price Target: $660
Current: $2.19
Upside: +30,036.99%
Nov 3, 2020
Upgrades: Perform
Price Target: n/a
Current: $78.20
Upside: -
Sep 15, 2020
Initiates: Perform
Price Target: n/a
Current: $4.03
Upside: -
Jun 24, 2020
Initiates: Outperform
Price Target: $100
Current: $23.17
Upside: +331.59%
Sep 12, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $70.63
Upside: -